-
1
-
-
67349184808
-
Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
-
J.L. Price, D.W. McKeel Jr, V.D. Buckles, C.M. Roe, C. Xiong, and M. Grundman et al. Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease Neurobiol Aging 30 2009 1026 1036
-
(2009)
Neurobiol Aging
, vol.30
, pp. 1026-1036
-
-
Price, J.L.1
McKeel, Jr.D.W.2
Buckles, V.D.3
Roe, C.M.4
Xiong, C.5
Grundman, M.6
-
4
-
-
84865529158
-
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
-
R.J. Bateman, C. Xiong, T.L.S. Benzinger, A.M. Fagan, A. Goate, and N.C. Fox et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease N Engl J Med 367 2012 795 804
-
(2012)
N Engl J Med
, vol.367
, pp. 795-804
-
-
Bateman, R.J.1
Xiong, C.2
Benzinger, T.L.S.3
Fagan, A.M.4
Goate, A.5
Fox, N.C.6
-
5
-
-
33750589818
-
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
-
DOI 10.1093/brain/awl269
-
K. Buerger, M. Ewers, T. Pirttilä, R. Zinkowski, I. Alafuzoff, and S.J. Teipel et al. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease Brain 129 2006 3035 3041 (Pubitemid 44684523)
-
(2006)
Brain
, vol.129
, Issue.11
, pp. 3035-3041
-
-
Buerger, K.1
Ewers, M.2
Pirttila, T.3
Zinkowski, R.4
Alafuzoff, I.5
Teipel, S.J.6
DeBernardis, J.7
Kerkman, D.8
McCulloch, C.9
Soininen, H.10
Hampel, H.11
-
6
-
-
0037135111
-
The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
-
J.J. Hardy, and D.J.D. Selkoe The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics Science 297 2002 353 356
-
(2002)
Science
, vol.297
, pp. 353-356
-
-
Hardy, J.J.1
Selkoe, D.J.D.2
-
7
-
-
4544306699
-
MRI and CSF studies in the early diagnosis of Alzheimer's disease
-
M.J.M. de Leon, S.S. DeSanti, R.R. Zinkowski, P.D.P. Mehta, D.D. Pratico, and S.S. Segal et al. MRI and CSF studies in the early diagnosis of Alzheimer's disease J Intern Med 256 2004 205 223
-
(2004)
J Intern Med
, vol.256
, pp. 205-223
-
-
De Leon, M.J.M.1
Desanti, S.S.2
Zinkowski, R.R.3
Mehta, P.D.P.4
Pratico, D.D.5
Segal, S.S.6
-
8
-
-
65249159879
-
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
-
L.M. Shaw, H. Vanderstichele, M. Knapik-Czajka, C.M. Clark, P.S. Aisen, and R.C. Petersen et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects Ann Neurol 65 2009 403 413
-
(2009)
Ann Neurol
, vol.65
, pp. 403-413
-
-
Shaw, L.M.1
Vanderstichele, H.2
Knapik-Czajka, M.3
Clark, C.M.4
Aisen, P.S.5
Petersen, R.C.6
-
9
-
-
84860832253
-
CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease
-
R. Tarawneh, J.-M. Lee, J.H. Ladenson, J.C. Morris, and D.M. Holtzman CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease Neurology 78 2012 709 719
-
(2012)
Neurology
, vol.78
, pp. 709-719
-
-
Tarawneh, R.1
Lee, J.-M.2
Ladenson, J.H.3
Morris, J.C.4
Holtzman, D.M.5
-
10
-
-
78049424619
-
YKL-40: A novel prognostic fluid biomarker for preclinical Alzheimer's disease
-
R. Craig-Schapiro, R.J. Perrin, C.M. Roe, C. Xiong, D. Carter, and N.J. Cairns et al. YKL-40: A novel prognostic fluid biomarker for preclinical Alzheimer's disease Biol Psychiatry 68 2010 903 912
-
(2010)
Biol Psychiatry
, vol.68
, pp. 903-912
-
-
Craig-Schapiro, R.1
Perrin, R.J.2
Roe, C.M.3
Xiong, C.4
Carter, D.5
Cairns, N.J.6
-
11
-
-
33947223454
-
42 ratio as a prediction of cognitive decline in nondemented older adults
-
DOI 10.1001/archneur.64.3.noc60123
-
A.M. Fagan, C.M. Roe, C. Xiong, M.A. Mintun, J.C. Morris, and D.M. Holtzman Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults Arch Neurol 64 2007 343 349 (Pubitemid 46425688)
-
(2007)
Archives of Neurology
, vol.64
, Issue.3
, pp. 343-349
-
-
Fagan, A.M.1
Roe, C.M.2
Xiong, C.3
Mintun, M.A.4
Morris, J.C.5
Holtzman, D.M.6
-
12
-
-
0025770134
-
The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease
-
J.L. Price, P.B. Davis, J.C. Morris, and D.L. White The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease Neurobiol Aging 12 1991 295 312
-
(1991)
Neurobiol Aging
, vol.12
, pp. 295-312
-
-
Price, J.L.1
Davis, P.B.2
Morris, J.C.3
White, D.L.4
-
13
-
-
0032989712
-
Tangles and plaques in nondemented aging and 'preclinical' alzheimer's disease
-
DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X
-
J.L. Price, and J.C. Morris Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease Ann Neurol 45 1999 358 368 (Pubitemid 29120041)
-
(1999)
Annals of Neurology
, vol.45
, Issue.3
, pp. 358-368
-
-
Price, J.L.1
Morris, J.C.2
-
14
-
-
84862753578
-
CSF biomarkers cutoffs: The importance of coincident neuropathological diseases
-
J.B. Toledo, J. Brettschneider, M. Grossman, S.E. Arnold, W.T. Hu, and S.X. Xie et al. CSF biomarkers cutoffs: The importance of coincident neuropathological diseases Acta Neuropathol 124 2012 23 35
-
(2012)
Acta Neuropathol
, vol.124
, pp. 23-35
-
-
Toledo, J.B.1
Brettschneider, J.2
Grossman, M.3
Arnold, S.E.4
Hu, W.T.5
Xie, S.X.6
-
15
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
-
G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944 (Pubitemid 14076461)
-
(1984)
Neurology
, vol.34
, Issue.7
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
-
16
-
-
33644832047
-
42 in humans
-
DOI 10.1002/ana.20730
-
A.M. Fagan, M.A. Mintun, R.H. Mach, S.-Y. Lee, C.S. Dence, and A.R. Shah et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans Ann Neurol 59 2006 512 519 (Pubitemid 43358072)
-
(2006)
Annals of Neurology
, vol.59
, Issue.3
, pp. 512-519
-
-
Fagan, A.M.1
Mintun, M.A.2
Mach, R.H.3
Lee, S.-Y.4
Dence, C.S.5
Shah, A.R.6
LaRossa, G.N.7
Spinner, M.L.8
Klunk, W.E.9
Mathis, C.A.10
DeKosky, S.T.11
Morris, J.C.12
Holtzman, D.M.13
-
17
-
-
84867119124
-
Cerebrospinal fluid APOE levels: An endophenotype for genetic studies for Alzheimer's disease
-
C. Cruchaga, J.S.K. Kauwe, P. Nowotny, K. Bales, E.H. Pickering, and K. Mayo et al. Cerebrospinal fluid APOE levels: An endophenotype for genetic studies for Alzheimer's disease Hum Mol Genet 21 2012 4558 4571
-
(2012)
Hum Mol Genet
, vol.21
, pp. 4558-4571
-
-
Cruchaga, C.1
Kauwe, J.S.K.2
Nowotny, P.3
Bales, K.4
Pickering, E.H.5
Mayo, K.6
-
18
-
-
84867340530
-
Plasma biomarkers associated with the apolipoprotein e genotype and Alzheimer disease
-
H.D. Soares, W.Z. Potter, E. Pickering, M. Kuhn, F.W. Immermann, and D.M. Shera et al. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease Arch Neurol 69 2012 1310 1317
-
(2012)
Arch Neurol
, vol.69
, pp. 1310-1317
-
-
Soares, H.D.1
Potter, W.Z.2
Pickering, E.3
Kuhn, M.4
Immermann, F.W.5
Shera, D.M.6
-
19
-
-
0036281211
-
Processing of gene expression data generated by quantitative real-time RT-PCR
-
1376, 1378-1379
-
P.Y. Muller, H. Janovjak, A.R. Miserez, and Z. Dobbie Processing of gene expression data generated by quantitative real-time RT-PCR BioTechniques 32 2002 1372 1374 1376, 1378-1379
-
(2002)
BioTechniques
, vol.32
, pp. 1372-1374
-
-
Muller, P.Y.1
Janovjak, H.2
Miserez, A.R.3
Dobbie, Z.4
-
20
-
-
79955431733
-
Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis
-
R. Craig-Schapiro, M. Kuhn, C. Xiong, E.H. Pickering, J. Liu, and T.P. Misko et al. Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis PLoS ONE 6 2011 e18850
-
(2011)
PLoS ONE
, vol.6
, pp. 18850
-
-
Craig-Schapiro, R.1
Kuhn, M.2
Xiong, C.3
Pickering, E.H.4
Liu, J.5
Misko, T.P.6
-
21
-
-
84866106602
-
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
-
W.T. Hu, D.M. Holtzman, A.M. Fagan, L.M. Shaw, R. Perrin, and S.E. Arnold et al. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease Neurology 79 2012 897 905
-
(2012)
Neurology
, vol.79
, pp. 897-905
-
-
Hu, W.T.1
Holtzman, D.M.2
Fagan, A.M.3
Shaw, L.M.4
Perrin, R.5
Arnold, S.E.6
-
22
-
-
43249090541
-
A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms
-
DOI 10.1002/gepi.20310
-
X. Gao, J. Starmer, and E.R. Martin A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms Genet Epidemiol 32 2008 361 369 (Pubitemid 351656307)
-
(2008)
Genetic Epidemiology
, vol.32
, Issue.4
, pp. 361-369
-
-
Gao, X.1
Starmer, J.2
Martin, E.R.3
-
23
-
-
84859223046
-
Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset
-
Alzheimer's Disease Neuroimaging Initiative
-
D. Johnstone, E.A. Milward, R. Berretta, P. Moscato Alzheimer's Disease Neuroimaging Initiative Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset PLoS One 7 2012 e34341
-
(2012)
PLoS One
, vol.7
, pp. 34341
-
-
Johnstone, D.1
Milward, E.A.2
Berretta, R.3
Moscato, P.4
-
24
-
-
66249098494
-
Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type
-
B.J. Snider, A.M. Fagan, C. Roe, A.R. Shah, E.A. Grant, and C. Xiong et al. Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type Arch Neurol 66 2009 638 645
-
(2009)
Arch Neurol
, vol.66
, pp. 638-645
-
-
Snider, B.J.1
Fagan, A.M.2
Roe, C.3
Shah, A.R.4
Grant, E.A.5
Xiong, C.6
-
25
-
-
0027425211
-
The Clinical Dementia Rating (CDR): Current version and scoring rules
-
J.C. Morris The Clinical Dementia Rating (CDR): Current version and scoring rules Neurology 43 1993 2412 2414 (Pubitemid 23346995)
-
(1993)
Neurology
, vol.43
, Issue.11
, pp. 2412-2414
-
-
Morris, J.C.1
-
26
-
-
0036326149
-
Errors produced on the mini-mental state examination and neuropsychological test performance in Alzheimer's disease, ischemic vascular dementia, and Parkinson's disease
-
DOI 10.1176/appi.neuropsych.14.3.311
-
A.L. Jefferson, S.A. Cosentino, S.K. Ball, B. Bogdanoff, N. Leopold, E. Kaplan, and D.J. Libon Errors produced on the mini-mental state examination and neuropsychological test performance in Alzheimer's disease, ischemic vascular dementia, and Parkinson's disease J Neuropsychiatry Clin Neurosci 14 2002 311 320 (Pubitemid 34827687)
-
(2002)
Journal of Neuropsychiatry and Clinical Neurosciences
, vol.14
, Issue.3
, pp. 311-320
-
-
Jefferson, A.L.1
Cosentino, S.A.2
Ball, S.K.3
Bogdanoff, B.4
Leopold, N.5
Kaplan, E.6
Libon, D.J.7
-
27
-
-
84870584668
-
Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains
-
C.M. Karch, A.T. Jeng, P. Nowotny, J. Cady, C. Cruchaga, and A.M. Goate Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains PLoS One 7 2012 e50976
-
(2012)
PLoS One
, vol.7
, pp. 50976
-
-
Karch, C.M.1
Jeng, A.T.2
Nowotny, P.3
Cady, J.4
Cruchaga, C.5
Goate, A.M.6
-
28
-
-
0025863618
-
Neuropathological stageing of Alzheimer-related changes
-
H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol 82 1991 239 259
-
(1991)
Acta Neuropathol
, vol.82
, pp. 239-259
-
-
Braak, H.1
Braak, E.2
-
29
-
-
79751476480
-
CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease
-
D. Chiasserini, L. Parnetti, U. Andreasson, H. Zetterberg, D. Giannandrea, P. Calabresi, and K. Blennow CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease J Alzheimers Dis 22 2010 1281 1288
-
(2010)
J Alzheimers Dis
, vol.22
, pp. 1281-1288
-
-
Chiasserini, D.1
Parnetti, L.2
Andreasson, U.3
Zetterberg, H.4
Giannandrea, D.5
Calabresi, P.6
Blennow, K.7
-
30
-
-
61449172037
-
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
-
D.W. Huang, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat Protoc 4 2009 44 57
-
(2009)
Nat Protoc
, vol.4
, pp. 44-57
-
-
Huang, D.W.1
Sherman, B.T.2
Lempicki, R.A.3
-
31
-
-
84862144659
-
Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease
-
A. Ohrfelt, U. Andreasson, A. Simon, H. Zetterberg, A. Edman, and W. Potter et al. Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease Dement Geriatr Cogn Dis Extra 1 2011 31 42
-
(2011)
Dement Geriatr Cogn Dis Extra
, vol.1
, pp. 31-42
-
-
Ohrfelt, A.1
Andreasson, U.2
Simon, A.3
Zetterberg, H.4
Edman, A.5
Potter, W.6
-
32
-
-
77953029039
-
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment
-
W.T. Hu, A. Chen-Plotkin, S.E. Arnold, M. Grossman, C.M. Clark, and L.M. Shaw et al. Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment Acta Neuropathol 119 2010 669 678
-
(2010)
Acta Neuropathol
, vol.119
, pp. 669-678
-
-
Hu, W.T.1
Chen-Plotkin, A.2
Arnold, S.E.3
Grossman, M.4
Clark, C.M.5
Shaw, L.M.6
-
33
-
-
44449118921
-
Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets
-
DOI 10.1038/nrd2589, PII NRD2589
-
M. Furuhashi, and G.S. Hotamisligil Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets Nat Rev Drug Discov 7 2008 489 503 (Pubitemid 351767117)
-
(2008)
Nature Reviews Drug Discovery
, vol.7
, Issue.6
, pp. 489-503
-
-
Furuhashi, M.1
Hotamisligil, G.S.2
-
34
-
-
0030923223
-
Free fatty acids stimulate the polymerization of tau and amyloid β peptides: In vitro evidence for a common effector of pathogenesis in Alzheimer's disease
-
D.M. Wilson, and L.I. Binder Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease Am J Pathol 150 1997 2181 2195 (Pubitemid 27233088)
-
(1997)
American Journal of Pathology
, vol.150
, Issue.6
, pp. 2181-2195
-
-
Wilson, D.M.1
Binder, L.I.2
-
35
-
-
79959772357
-
Human apoE isoforms differentially regulate brain amyloid-β peptide clearance
-
J.M. Castellano, J. Kim, F.R. Stewart, H. Jiang, R.B. DeMattos, and B.W. Patterson et al. Human apoE isoforms differentially regulate brain amyloid-β peptide clearance Sci Transl Med 3 2011 89ra57
-
(2011)
Sci Transl Med
, vol.3
-
-
Castellano, J.M.1
Kim, J.2
Stewart, F.R.3
Jiang, H.4
Demattos, R.B.5
Patterson, B.W.6
-
36
-
-
79955484414
-
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
-
P. Hollingworth, D. Harold, R. Sims, A. Gerrish, J.-C. Lambert, and M.M. Carrasquillo et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease Nat Genet 43 2011 429 435
-
(2011)
Nat Genet
, vol.43
, pp. 429-435
-
-
Hollingworth, P.1
Harold, D.2
Sims, R.3
Gerrish, A.4
Lambert, J.-C.5
Carrasquillo, M.M.6
|